D-penicillamine-induced agranulocytosis: hematological remission upon treatment with recombinant GM-CSF.
Petrides
P E
PE
Medizinische Klinik III, Universität München.
Gerhartz
H H
HH
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced* / Q000276:immunology / Q000628:therapy*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001853:Bone Marrow / Q000187:drug effects; D004334:Drug Administration Schedule; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D007958:Leukocyte Count / Q000187:drug effects; D010396:Penicillamine / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D010396:Penicillamine